{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T18:59:43Z","timestamp":1789412383954,"version":"build-2803163510"},"reference-count":259,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.nbd.2016.04.007","type":"journal-article","created":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T18:04:22Z","timestamp":1462125862000},"page":"103-113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"PB","title":["Insulin-like growth factor 1 in diabetic neuropathy and amyotrophic lateral sclerosis"],"prefix":"10.1016","volume":"97","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0678-1752","authenticated-orcid":false,"given":"Stefanie","family":"Rauskolb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Dombert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4737-2974","authenticated-orcid":false,"given":"Michael","family":"Sendtner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2016.04.007_bb0005","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/BF02816121","article-title":"Growth factor receptors in amyotrophic lateral sclerosis","volume":"9","author":"Adem","year":"1994","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.nbd.2016.04.007_bb0010","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/BF01277964","article-title":"Insulin-like growth factor-1 receptors in human spinal cord: changes in amyotrophic lateral sclerosis","volume":"97","author":"Adem","year":"1994","journal-title":"J. Neural Transm. Gen. Sect."},{"key":"10.1016\/j.nbd.2016.04.007_bb0015","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.neuron.2013.12.018","article-title":"Axonal transport of TDP-43 mRNA granules is impaired by ALS-causing mutations","volume":"81","author":"Alami","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2016.04.007_bb0020","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","article-title":"Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation","volume":"15","author":"Alberti","year":"1998","journal-title":"Diabet. Med."},{"key":"10.1016\/j.nbd.2016.04.007_bb0025","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.pneurobio.2009.07.008","article-title":"Circulating insulin-like growth factor I and cognitive function: neuromodulation throughout the lifespan","volume":"89","author":"Aleman","year":"2009","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nbd.2016.04.007_bb0030","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00401-013-1149-y","article-title":"Modeling key pathological features of frontotemporal dementia with C9ORF72 repeat expansion in iPSC-derived human neurons","volume":"126","author":"Almeida","year":"2013","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2016.04.007_bb0035","doi-asserted-by":"crossref","first-page":"440","DOI":"10.2337\/diab.45.4.440","article-title":"Isokinetic muscle strength in long-term IDDM patients in relation to diabetic complications","volume":"45","author":"Andersen","year":"1996","journal-title":"Diabetes"},{"key":"10.1016\/j.nbd.2016.04.007_bb0040","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1007\/s001250050788","article-title":"Muscular atrophy in diabetic neuropathy: a stereological magnetic resonance imaging study","volume":"40","author":"Andersen","year":"1997","journal-title":"Diabetologia"},{"key":"10.1016\/j.nbd.2016.04.007_bb0045","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.2337\/diabetes.53.6.1543","article-title":"Muscle strength in type 2 diabetes","volume":"53","author":"Andersen","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.nbd.2016.04.007_bb0050","doi-asserted-by":"crossref","first-page":"806","DOI":"10.2337\/diabetes.55.03.06.db05-1237","article-title":"Muscle weakness: a progressive late complication in diabetic distal symmetric polyneuropathy","volume":"55","author":"Andreassen","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.nbd.2016.04.007_bb0055","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.brainres.2004.02.049","article-title":"Different levels of neuroprotection by two insulin-like growth factor-I splice variants","volume":"1009","author":"Aperghis","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2016.04.007_bb0060","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1515\/CCLM.2001.055","article-title":"Neurotrophic factor therapy\u2013prospects and problems","volume":"39","author":"Apfel","year":"2001","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.nbd.2016.04.007_bb0065","first-page":"4","article-title":"The microglial-motoneuron dialogue in ALS","volume":"30","author":"Appel","year":"2011","journal-title":"Acta Myol."},{"key":"10.1016\/j.nbd.2016.04.007_bb0070","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1523\/JNEUROSCI.10-11-03507.1990","article-title":"Survival effect of ciliary neurotrophic factor (CNTF) on chick embryonic motoneurons in culture: comparison with other neurotrophic factors and cytokines","volume":"10","author":"Arakawa","year":"1990","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2016.04.007_bb0075","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1016\/j.febslet.2007.05.030","article-title":"The IGF-I splice variant MGF increases progenitor cells in ALS, dystrophic, and normal muscle","volume":"581","author":"Ates","year":"2007","journal-title":"FEBS Lett."},{"key":"10.1016\/j.nbd.2016.04.007_bb0080","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1468-1331.2004.00987.x","article-title":"Effects of intraperitoneal injection of Rofecoxib in a mouse model of ALS","volume":"12","author":"Azari","year":"2005","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.nbd.2016.04.007_bb0085","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nature02544","article-title":"VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model","volume":"429","author":"Azzouz","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2016.04.007_bb0090","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.tem.2005.05.005","article-title":"IGF-binding proteins\u2013the pieces are falling into place","volume":"16","author":"Bach","year":"2005","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.nbd.2016.04.007_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002740","article-title":"Adaptive immune neuroprotection in G93A-SOD1 amyotrophic lateral sclerosis mice","volume":"3","author":"Banerjee","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2016.04.007_bb0100","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s00702-010-0429-0","article-title":"Motor neuron-immune interactions: the vicious circle of ALS","volume":"117","author":"Barbeito","year":"2010","journal-title":"J. Neural. Transm (Vienna)"},{"key":"10.1016\/j.nbd.2016.04.007_bb0105","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1006\/exnr.1998.6984","article-title":"Beneficial effects of lysine acetylsalicylate, a soluble salt of aspirin, on motor performance in a transgenic model of amyotrophic lateral sclerosis","volume":"155","author":"Barneoud","year":"1999","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2016.04.007_bb0110","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002064.pub3","article-title":"Recombinant human insulin-like growth factor I (rhIGF-I) for the treatment of amyotrophic lateral sclerosis\/motor neuron disease","volume":"11","author":"Beauverd","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.nbd.2016.04.007_bb0115","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/0896-6273(95)90216-3","article-title":"Igf1 gene disruption results in reduced brain size, CNS hypomyelination, and loss of hippocampal granule and striatal parvalbumin-containing neurons","volume":"14","author":"Beck","year":"1995","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2016.04.007_bb0120","doi-asserted-by":"crossref","first-page":"16021","DOI":"10.1073\/pnas.0607423103","article-title":"Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis","volume":"103","author":"Beers","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2016.04.007_bb0125","doi-asserted-by":"crossref","first-page":"15558","DOI":"10.1073\/pnas.0807419105","article-title":"CD4+ T cells support glial neuroprotection, slow disease progression, and modify glial morphology in an animal model of inherited ALS","volume":"105","author":"Beers","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2016.04.007_bb0130","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1111\/j.1468-1331.2006.01503.x","article-title":"Comparison of the growth hormone, IGF-1 and insulin in cerebrospinal fluid and serum between patients with motor neuron disease and healthy controls","volume":"13","author":"Bilic","year":"2006","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.nbd.2016.04.007_bb0135","doi-asserted-by":"crossref","first-page":"5803","DOI":"10.1073\/pnas.1202922109","article-title":"Mutant induced pluripotent stem cell lines recapitulate aspects of TDP-43 proteinopathies and reveal cell-specific vulnerability","volume":"109","author":"Bilican","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2016.04.007_bb0140","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1126\/science.1123511","article-title":"Onset and progression in inherited ALS determined by motor neurons and microglia","volume":"312","author":"Boillee","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.nbd.2016.04.007_bb0145","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.1523\/JNEUROSCI.11-11-03442.1991","article-title":"Transient IGF-I gene expression during the maturation of functionally related central projection neurons","volume":"11","author":"Bondy","year":"1991","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2016.04.007_bb0150","doi-asserted-by":"crossref","first-page":"5092","DOI":"10.1523\/JNEUROSCI.13-12-05092.1993","article-title":"Correlation between insulin-like growth factor (IGF)-binding protein 5 and IGF-I gene expression during brain development","volume":"13","author":"Bondy","year":"1993","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2016.04.007_bb0155","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/0306-4522(92)90193-6","article-title":"Cellular pattern of type-I insulin-like growth factor receptor gene expression during maturation of the rat brain: comparison with insulin-like growth factors I and II","volume":"46","author":"Bondy","year":"1992","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2016.04.007_bb0160","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1126\/science.286.5443.1358","article-title":"Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms","volume":"286","author":"Bonni","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.nbd.2016.04.007_bb0165","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1212\/WNL.51.2.583","article-title":"A placebo-controlled trial of insulin-like growth factor-I in amyotrophic lateral sclerosis. European ALS\/IGF-I Study Group","volume":"51","author":"Borasio","year":"1998","journal-title":"Neurology"},{"issue":"Suppl. 3","key":"10.1016\/j.nbd.2016.04.007_bb0170","first-page":"55","article-title":"Guidelines for diagnosis and outpatient management of diabetic peripheral neuropathy. European Association for the Study of Diabetes, Neurodiab","volume":"24","author":"Boulton","year":"1998","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.nbd.2016.04.007_bb0175","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1136\/jnnp.50.6.792","article-title":"Serum insulin-like growth factor-I levels in amyotrophic lateral sclerosis","volume":"50","author":"Braunstein","year":"1987","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.nbd.2016.04.007_bb0180","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0896-6273(00)80272-X","article-title":"ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions","volume":"18","author":"Bruijn","year":"1997","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2016.04.007_bb0185","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1126\/science.281.5384.1851","article-title":"Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1","volume":"281","author":"Bruijn","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.nbd.2016.04.007_bb0190","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0092-8674(00)80595-4","article-title":"Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor","volume":"96","author":"Brunet","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2016.04.007_bb0195","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.mcn.2013.07.007","article-title":"A cellular model for sporadic ALS using patient-derived induced pluripotent stem cells","volume":"56","author":"Burkhardt","year":"2013","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.nbd.2016.04.007_bb0200","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1083\/jcb.110.4.1307","article-title":"Nerve sprouting in innervated adult skeletal muscle induced by exposure to elevated levels of insulin-like growth factors","volume":"110","author":"Caroni","year":"1990","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.nbd.2016.04.007_bb0205","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/nm1202-793","article-title":"Serum insulin-like growth factor I regulates brain amyloid-beta levels","volume":"8","author":"Carro","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.nbd.2016.04.007_bb0210","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0092-8674(00)81732-8","article-title":"Apaf1 (CED-4 homolog) regulates programmed cell death in mammalian development","volume":"94","author":"Cecconi","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2016.04.007_bb0215","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.stem.2014.02.004","article-title":"Modeling ALS with iPSCs reveals that mutant SOD1 misregulates neurofilament balance in motor neurons","volume":"14","author":"Chen","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.nbd.2016.04.007_bb0220","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1046\/j.1471-4159.1996.66020525.x","article-title":"Characterization of insulin-like growth factor-I and its receptor and binding proteins in transected nerves and cultured Schwann cells","volume":"66","author":"Cheng","year":"1996","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2016.04.007_bb0225","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1749-6632.1999.tb08575.x","article-title":"IGF-I promotes peripheral nervous system myelination","volume":"883","author":"Cheng","year":"1999","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.nbd.2016.04.007_bb0230","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1126\/science.aaa9344","article-title":"Neurodegeneration. C9ORF72 repeat expansions in mice cause TDP-43 pathology, neuronal loss, and behavioral deficits","volume":"348","author":"Chew","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.nbd.2016.04.007_bb0235","doi-asserted-by":"crossref","first-page":"17913","DOI":"10.1073\/pnas.0804610105","article-title":"T lymphocytes potentiate endogenous neuroprotective inflammation in a mouse model of ALS","volume":"105","author":"Chiu","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2016.04.007_bb0240","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1038\/mt.2008.115","article-title":"Systemic Insulin-like growth factor-1 reverses hypoalgesia and improves mobility in a mouse model of diabetic peripheral neuropathy","volume":"16","author":"Chu","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.nbd.2016.04.007_bb0245","doi-asserted-by":"crossref","first-page":"604","DOI":"10.2337\/diab.28.6.604","article-title":"Diabetic neuropathy\u2013new concepts of its etiology","volume":"28","author":"Clements","year":"1979","journal-title":"Diabetes"},{"key":"10.1016\/j.nbd.2016.04.007_bb0250","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.cell.2009.11.014","article-title":"Reduced IGF-1 signaling delays age-associated proteotoxicity in mice","volume":"139","author":"Cohen","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2016.04.007_bb0255","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/S0022-3565(25)10697-6","article-title":"Systemic administration of rhIGF-I enhanced regeneration after sciatic nerve crush in mice","volume":"274","author":"Contreras","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.nbd.2016.04.007_bb0260","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00401-014-1251-9","article-title":"The widening spectrum of C9ORF72-related disease; genotype\/phenotype correlations and potential modifiers of clinical phenotype","volume":"127","author":"Cooper-Knock","year":"2014","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2016.04.007_bb0265","doi-asserted-by":"crossref","first-page":"3782","DOI":"10.1093\/hmg\/ddq293","article-title":"Systemic transplantation of c-kit+cells exerts a therapeutic effect in a model of amyotrophic lateral sclerosis","volume":"19","author":"Corti","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2016.04.007_bb0270","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/ana.20552","article-title":"Manganese porphyrin given at symptom onset markedly extends survival of ALS mice","volume":"58","author":"Crow","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2016.04.007_bb0275","doi-asserted-by":"crossref","first-page":"8918","DOI":"10.1074\/jbc.M414267200","article-title":"Inhibition of Src-like kinases reveals Akt-dependent and -independent pathways in insulin-like growth factor I-mediated oligodendrocyte progenitor survival","volume":"280","author":"Cui","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2016.04.007_bb0280","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0006-8993(95)00063-V","article-title":"Neuropathological changes in two lines of mice carrying a transgene for mutant human Cu,Zn SOD, and in mice overexpressing wild type human SOD: a model of familial amyotrophic lateral sclerosis (FALS)","volume":"676","author":"Dal Canto","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2016.04.007_bb0285","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s004010050650","article-title":"A low expressor line of transgenic mice carrying a mutant human Cu,Zn superoxide dismutase (SOD1) gene develops pathological changes that most closely resemble those in human amyotrophic lateral sclerosis","volume":"93","author":"Dal Canto","year":"1997","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2016.04.007_bb0290","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/(SICI)1097-4695(19980905)36:3<379::AID-NEU6>3.0.CO;2-T","article-title":"Mechanisms of insulin-like growth factor regulation of programmed cell death of developing avian motoneurons","volume":"36","author":"D'Costa","year":"1998","journal-title":"J. Neurobiol."},{"key":"10.1016\/j.nbd.2016.04.007_bb0295","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1080\/15384101.2015.1093712","article-title":"A perspective on stem cell modeling of amyotrophic lateral sclerosis","volume":"14","author":"de Boer","year":"2015","journal-title":"Cell Cycle"},{"key":"10.1016\/j.nbd.2016.04.007_bb0300","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nrd917","article-title":"Structural biology of insulin and IGF1 receptors: implications for drug design","volume":"1","author":"De Meyts","year":"2002","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.nbd.2016.04.007_bb0305","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.neuron.2011.09.011","article-title":"Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS","volume":"72","author":"DeJesus-Hernandez","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2016.04.007_bb0310","first-page":"9","article-title":"A double-blind, placebo-controlled randomized clinical trial of alpha-tocopherol (vitamin E) in the treatment of amyotrophic lateral sclerosis. ALS riluzole-tocopherol Study Group. Amyotroph Lateral Scler Other Motor","volume":"2","author":"Desnuelle","year":"2001","journal-title":"Neuron. Disord."},{"key":"10.1016\/j.nbd.2016.04.007_bb0315","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1212\/WNL.53.5.1059","article-title":"Nutritional status is a prognostic factor for survival in ALS patients","volume":"53","author":"Desport","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2016.04.007_bb0320","doi-asserted-by":"crossref","first-page":"5999","DOI":"10.1038\/ncomms6999","article-title":"Human iPSC-derived motoneurons harbouring TARDBP or C9ORF72 ALS mutations are dysfunctional despite maintaining viability","volume":"6","author":"Devlin","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.nbd.2016.04.007_bb0325","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1083\/jcb.200407021","article-title":"Muscle expression of a local Igf-1 isoform protects motor neurons in an ALS mouse model","volume":"168","author":"Dobrowolny","year":"2005","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.nbd.2016.04.007_bb0330","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1179\/174313208X281235","article-title":"Local expression of mIgf-1 modulates ubiquitin, caspase and CDK5 expression in skeletal muscle of an ALS mouse model","volume":"30","author":"Dobrowolny","year":"2008","journal-title":"Neurol. Res."},{"key":"10.1016\/j.nbd.2016.04.007_bb0335","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/mt.2008.60","article-title":"Delivery of AAV-IGF-1 to the CNS extends survival in ALS mice through modification of aberrant glial cell activity","volume":"16","author":"Dodge","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.nbd.2016.04.007_bb0340","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.neuron.2013.10.015","article-title":"RNA toxicity from the ALS\/FTD C9ORF72 expansion is mitigated by antisense intervention","volume":"80","author":"Donnelly","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2016.04.007_bb0345","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0169-328X(96)00081-2","article-title":"Distribution and levels of insulin-like growth factor (IGF-I and IGF-II) and insulin receptor binding sites in the spinal cords of amyotrophic lateral sclerosis (ALS) patients","volume":"41","author":"Dore","year":"1996","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.nbd.2016.04.007_bb0350","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1677\/joe.0.1750041","article-title":"Specifying the cellular responses to IGF signals: roles of IGF-binding proteins","volume":"175","author":"Duan","year":"2002","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.nbd.2016.04.007_bb0355","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3004052","article-title":"Drug screening for ALS using patient-specific induced pluripotent stem cells","volume":"4","author":"Egawa","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.nbd.2016.04.007_bb0360","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/hmg\/dds479","article-title":"Ataxin-2 interacts with FUS and intermediate-length polyglutamine expansions enhance FUS-related pathology in amyotrophic lateral sclerosis","volume":"22","author":"Farg","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2016.04.007_bb0365","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1006\/nbdi.1997.0156","article-title":"Insulin-like growth factors regulate neuronal differentiation and survival","volume":"4","author":"Feldman","year":"1997","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2016.04.007_bb0370","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/ana.24113","article-title":"Intraspinal neural stem cell transplantation in amyotrophic lateral sclerosis: phase 1 trial outcomes","volume":"75","author":"Feldman","year":"2014","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2016.04.007_bb0375","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nrn3209","article-title":"The many faces of insulin-like peptide signalling in the brain","volume":"13","author":"Fernandez","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2016.04.007_bb0380","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/nrneurol.2011.152","article-title":"Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis","volume":"7","author":"Ferraiuolo","year":"2011","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.nbd.2016.04.007_bb0385","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022374","article-title":"Abnormal changes in NKT cells, the IGF-1 axis, and liver pathology in an animal model of ALS","volume":"6","author":"Finkelstein","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2016.04.007_bb0390","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ejmg.2014.01.002","article-title":"Recent progress in the genetics of motor neuron disease","volume":"57","author":"Finsterer","year":"2014","journal-title":"Eur. J. Med. Genet."},{"key":"10.1016\/j.nbd.2016.04.007_bb0395","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1210\/er.2001-0033","article-title":"Cellular actions of the insulin-like growth factor binding proteins","volume":"23","author":"Firth","year":"2002","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.nbd.2016.04.007_bb0400","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.neuron.2014.01.013","article-title":"Microglia induce motor neuron death via the classical NF-kappaB pathway in amyotrophic lateral sclerosis","volume":"81","author":"Frakes","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2016.04.007_bb0405","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/(SICI)1097-4695(199904)39:1<142::AID-NEU11>3.0.CO;2-H","article-title":"IGF-I deficient mice show reduced peripheral nerve conduction velocities and decreased axonal diameters and respond to exogenous IGF-I treatment","volume":"39","author":"Gao","year":"1999","journal-title":"J. Neurobiol."},{"key":"10.1016\/j.nbd.2016.04.007_bb0410","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0036000","article-title":"Early functional deficit and microglial disturbances in a mouse model of amyotrophic lateral sclerosis","volume":"7","author":"Gerber","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2016.04.007_bb0415","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/ana.21344","article-title":"TDP-43 A315T mutation in familial motor neuron disease","volume":"63","author":"Gitcho","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2016.04.007_bb0420","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1002\/stem.1079","article-title":"Lumbar intraspinal injection of neural stem cells in patients with amyotrophic lateral sclerosis: results of a phase I trial in 12 patients","volume":"30","author":"Glass","year":"2012","journal-title":"Stem Cells"},{"key":"10.1016\/j.nbd.2016.04.007_bb0425","doi-asserted-by":"crossref","first-page":"11500","DOI":"10.1523\/JNEUROSCI.0343-15.2015","article-title":"Blocking IGF Signaling in Adult Neurons Alleviates Alzheimer's Disease Pathology through Amyloid-beta Clearance","volume":"35","author":"Gontier","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2016.04.007_bb0430","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.neuint.2007.04.030","article-title":"Neuroprotective effects of short peptides derived from the Insulin-like growth factor 1","volume":"51","author":"Gorecki","year":"2007","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.nbd.2016.04.007_bb0435","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/j.1471-4159.2010.06683.x","article-title":"Intracerebroventricular infusion of monoclonal antibody or its derived Fab fragment against misfolded forms of SOD1 mutant delays mortality in a mouse model of ALS","volume":"113","author":"Gros-Louis","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2016.04.007_bb0440","first-page":"76","article-title":"The change of insulin-like growth factor-1 in diabetic patients with neuropathy","volume":"112","author":"Guo","year":"1999","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.nbd.2016.04.007_bb0445","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1056\/NEJM199412223312516","article-title":"Transgenic-mouse model of amyotrophic lateral sclerosis","volume":"331","author":"Gurney","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.nbd.2016.04.007_bb0450","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/ana.410390203","article-title":"Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis","volume":"39","author":"Gurney","year":"1996","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2016.04.007_bb0455","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1212\/WNL.50.1.62","article-title":"Riluzole preserves motor function in a transgenic model of familial amyotrophic lateral sclerosis","volume":"50","author":"Gurney","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2016.04.007_bb0460","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.nbd.2006.12.013","article-title":"Therapeutic immunization with a glatiramer acetate derivative does not alter survival in G93A and G37R SOD1 mouse models of familial ALS","volume":"26","author":"Haenggeli","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2016.04.007_bb0465","doi-asserted-by":"crossref","first-page":"17106","DOI":"10.1074\/jbc.M114.631291","article-title":"Hyperglycemia Promotes Schwann Cell De-differentiation and De-myelination via Sorbitol Accumulation and Igf1 Protein Down-regulation","volume":"290","author":"Hao","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"Pt 3","key":"10.1016\/j.nbd.2016.04.007_bb0470","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1093\/brain\/118.3.707","article-title":"Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction","volume":"118","author":"Haverkamp","year":"1995","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2016.04.007_bb0475","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s11481-009-9171-5","article-title":"Microglia in ALS: the good, the bad, and the resting","volume":"4","author":"Henkel","year":"2009","journal-title":"J. NeuroImmune Pharmacol."},{"key":"10.1016\/j.nbd.2016.04.007_bb0480","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/72842","article-title":"Fus deficiency in mice results in defective B-lymphocyte development and activation, high levels of chromosomal instability and perinatal death","volume":"24","author":"Hicks","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2016.04.007_bb0485","doi-asserted-by":"crossref","first-page":"10201","DOI":"10.1523\/JNEUROSCI.3246-04.2004","article-title":"Insulin-like growth factor-I accelerates the cell cycle by decreasing G1 phase length and increases cell cycle reentry in the embryonic cerebral cortex","volume":"24","author":"Hodge","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2016.04.007_bb0490","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ijdevneu.2007.03.004","article-title":"Insulin-like growth factor-I (IGF-I) inhibits neuronal apoptosis in the developing cerebral cortex in vivo","volume":"25","author":"Hodge","year":"2007","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.nbd.2016.04.007_bb0495","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.ghir.2007.06.002","article-title":"Circulating insulin-like growth factors and related binding proteins are selectively altered in amyotrophic lateral sclerosis and multiple sclerosis","volume":"17","author":"Hosback","year":"2007","journal-title":"Growth Hormon. IGF Res."},{"key":"10.1016\/j.nbd.2016.04.007_bb0500","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0079-6123(08)60542-7","article-title":"Naturally occurring and axotomy-induced motoneuron death and its prevention by neurotrophic agents: a comparison between chick and mouse","volume":"102","author":"Houenou","year":"1994","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.nbd.2016.04.007_bb0505","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/jnr.490360607","article-title":"Members of several gene families influence survival of rat motoneurons in vitro and in vivo","volume":"36","author":"Hughes","year":"1993","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.nbd.2016.04.007_bb0510","first-page":"761","article-title":"The insulin-like growth factor-binding protein (IGFBP) superfamily","volume":"20","author":"Hwa","year":"1999","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.nbd.2016.04.007_bb0515","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0163-7258(94)90007-8","article-title":"Role of insulin-like growth factors in peripheral nerve regeneration","volume":"62","author":"Ishii","year":"1994","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.nbd.2016.04.007_bb0520","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.scr.2015.09.006","article-title":"Amyotrophic lateral sclerosis models derived from human embryonic stem cells with different superoxide dismutase 1 mutations exhibit differential drug responses","volume":"15","author":"Isobe","year":"2015","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.nbd.2016.04.007_bb0525","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1523\/JNEUROSCI.5258-07.2008","article-title":"Neuron-specific expression of mutant superoxide dismutase is sufficient to induce amyotrophic lateral sclerosis in transgenic mice","volume":"28","author":"Jaarsma","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2016.04.007_bb0530","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1002\/acn3.141","article-title":"Inhibiting drug efflux transporters improves efficacy of ALS therapeutics","volume":"1","author":"Jablonski","year":"2014","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.nbd.2016.04.007_bb0535","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0022-510X(00)00421-4","article-title":"Beneficial effect of ginseng root in SOD-1 (G93A) transgenic mice","volume":"180","author":"Jiang","year":"2000","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.nbd.2016.04.007_bb0540","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.neuroscience.2014.03.047","article-title":"Guanabenz delays the onset of disease symptoms, extends lifespan, improves motor performance and attenuates motor neuron loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis","volume":"277","author":"Jiang","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2016.04.007_bb0545","doi-asserted-by":"crossref","first-page":"12571","DOI":"10.1073\/pnas.220417997","article-title":"Formation of high molecular weight complexes of mutant Cu, Zn-superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis","volume":"97","author":"Johnston","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2016.04.007_bb0550","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.bbadis.2006.03.006","article-title":"Transgenic mouse models of amyotrophic lateral sclerosis","volume":"1762","author":"Julien","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.nbd.2016.04.007_bb0555","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/ng.132","article-title":"TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis","volume":"40","author":"Kabashi","year":"2008","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2016.04.007_bb0560","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s004010050764","article-title":"Reactive, degenerative, and proliferative Schwann cell responses in experimental galactose and human diabetic neuropathy","volume":"95","author":"Kalichman","year":"1998","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2016.04.007_bb0565","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/ajcn\/63.1.130","article-title":"Nutritional status of patients with amyotrophic lateral sclerosis: relation to the proximity of death","volume":"63","author":"Kasarskis","year":"1996","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.nbd.2016.04.007_bb0570","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1126\/science.1086137","article-title":"Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model","volume":"301","author":"Kaspar","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.nbd.2016.04.007_bb0575","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/BF00313611","article-title":"Insulin-like and fibroblast growth factors in spinal cords, nerve roots and skeletal muscle of human controls and patients with amyotrophic lateral sclerosis","volume":"87","author":"Kerkhoff","year":"1994","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2016.04.007_bb0580","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1523\/JNEUROSCI.5253-05.2006","article-title":"Thalidomide and lenalidomide extend survival in a transgenic mouse model of amyotrophic lateral sclerosis","volume":"26","author":"Kiaei","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2016.04.007_bb0585","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1046\/j.1471-4159.1998.71031333.x","article-title":"Differential regulation of focal adhesion kinase and mitogen-activated protein kinase tyrosine phosphorylation during insulin-like growth factor-I-mediated cytoskeletal reorganization","volume":"71","author":"Kim","year":"1998","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2016.04.007_bb0590","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.stem.2014.03.004","article-title":"Pathways disrupted in human ALS motor neurons identified through genetic correction of mutant SOD1","volume":"14","author":"Kiskinis","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.nbd.2016.04.007_bb0595","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/6568","article-title":"Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis","volume":"5","author":"Klivenyi","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.nbd.2016.04.007_bb0600","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/ana.24453","article-title":"C9orf72 ablation in mice does not cause motor neuron degeneration or motor deficits","volume":"78","author":"Koppers","year":"2015","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2016.04.007_bb0605","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1006\/nbdi.2002.0487","article-title":"Minocycline slows disease progression in a mouse model of amyotrophic lateral sclerosis","volume":"10","author":"Kriz","year":"2002","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2016.04.007_bb0610","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/ana.10500","article-title":"Efficient three-drug cocktail for disease induced by mutant superoxide dismutase","volume":"53","author":"Kriz","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2016.04.007_bb0615","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/ncpneuro0853","article-title":"Diagnosis and treatment of bulbar symptoms in amyotrophic lateral sclerosis","volume":"4","author":"Kuhnlein","year":"2008","journal-title":"Nat. Clin. Pract. Neurol."},{"key":"10.1016\/j.nbd.2016.04.007_bb0620","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/384368a0","article-title":"Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice","volume":"384","author":"Kuida","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2016.04.007_bb0625","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/emboj\/19.3.453","article-title":"Male sterility and enhanced radiation sensitivity in TLS(\u2212\/\u2212) mice","volume":"19","author":"Kuroda","year":"2000","journal-title":"EMBO J."},{"key":"10.1016\/j.nbd.2016.04.007_bb0630","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1126\/science.1166066","article-title":"Mutations in the FUS\/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis","volume":"323","author":"Kwiatkowski","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.nbd.2016.04.007_bb0635","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1212\/WNL.49.6.1621","article-title":"Effect of recombinant human insulin-like growth factor-I on progression of ALS. A placebo-controlled study. The North America ALS\/IGF-I Study Group","volume":"49","author":"Lai","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2016.04.007_bb0640","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/humu.22319","article-title":"TARDBP and FUS mutations associated with amyotrophic lateral sclerosis: summary and update","volume":"34","author":"Lattante","year":"2013","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.nbd.2016.04.007_bb0645","series-title":"Modeling ALS and FTD with iPSC-derived Neurons","author":"Lee","year":"2015"},{"key":"10.1016\/j.nbd.2016.04.007_bb0650","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1210\/edrv-16-2-143","article-title":"Molecular and cellular aspects of the insulin-like growth factor I receptor","volume":"16","author":"LeRoith","year":"1995","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.nbd.2016.04.007_bb0655","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nrn3982","article-title":"Neurodegenerative disease: expanding neurodegeneration modelling","volume":"16","author":"Lewis","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2016.04.007_bb0660","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1006\/exnr.1993.1177","article-title":"Insulin-like growth factor-I: potential for treatment of motor neuronal disorders","volume":"124","author":"Lewis","year":"1993","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2016.04.007_bb0665","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1126\/science.288.5464.335","article-title":"Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model","volume":"288","author":"Li","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.nbd.2016.04.007_bb0670","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.expneurol.2012.06.011","article-title":"Transformation from a neuroprotective to a neurotoxic microglial phenotype in a mouse model of ALS","volume":"237","author":"Liao","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2016.04.007_bb0675","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.neuron.2013.07.033","article-title":"Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis","volume":"79","author":"Ling","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2016.04.007_bb0680","doi-asserted-by":"crossref","first-page":"4825","DOI":"10.1523\/JNEUROSCI.22-12-04825.2002","article-title":"Accumulation of SOD1 mutants in postnatal motoneurons does not cause motoneuron pathology or motoneuron disease","volume":"22","author":"Lino","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2016.04.007_bb0685","first-page":"59","article-title":"Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r)","volume":"75","author":"Liu","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2016.04.007_bb0690","doi-asserted-by":"crossref","first-page":"32419","DOI":"10.1074\/jbc.C100299200","article-title":"Identification of a nonpeptide ligand that releases bioactive insulin-like growth factor-I from its binding protein complex","volume":"276","author":"Liu","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2016.04.007_bb0695","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.neuron.2004.06.016","article-title":"Toxicity of familial ALS-linked SOD1 mutants from selective recruitment to spinal mitochondria","volume":"43","author":"Liu","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2016.04.007_bb0700","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/nn1520","article-title":"Ryk-mediated Wnt repulsion regulates posterior-directed growth of corticospinal tract","volume":"8","author":"Liu","year":"2005","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2016.04.007_bb0705","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1038\/nn1988","article-title":"Glial cells as intrinsic components of non-cell-autonomous neurodegenerative disease","volume":"10","author":"Lobsiger","year":"2007","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2016.04.007_bb0710","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/mus.22288","article-title":"Impaired expression of insulin-like growth factor-1 system in skeletal muscle of amyotrophic lateral sclerosis patients","volume":"45","author":"Lunetta","year":"2012","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nbd.2016.04.007_bb0715","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1002\/stem.1933","article-title":"Autocrine production of IGF-I increases stem cell-mediated neuroprotection","volume":"33","author":"Lunn","year":"2015","journal-title":"Stem Cells"},{"key":"10.1016\/j.nbd.2016.04.007_bb0720","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0896-6273(03)00116-8","article-title":"Neuronal or glial progeny: regional differences in radial glia fate","volume":"37","author":"Malatesta","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2016.04.007_bb0725","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1007\/s13311-012-0140-y","article-title":"Sigma-1R agonist improves motor function and motoneuron survival in ALS mice","volume":"9","author":"Mancuso","year":"2012","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.nbd.2016.04.007_bb0730","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/cne.21160","article-title":"Motor neuron degeneration in amyotrophic lateral sclerosis mutant superoxide dismutase-1 transgenic mice: mechanisms of mitochondriopathy and cell death","volume":"500","author":"Martin","year":"2007","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.nbd.2016.04.007_bb0735","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1464-5491.1995.tb02086.x","article-title":"Insulin-like growth factor-I and IGF-I receptors in diabetic patients with neuropathy","volume":"12","author":"Migdalis","year":"1995","journal-title":"Diabet. Med."},{"key":"10.1016\/j.nbd.2016.04.007_bb0740","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1002\/ana.20453","article-title":"Virus-delivered small RNA silencing sustains strength in amyotrophic lateral sclerosis","volume":"57","author":"Miller","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2016.04.007_bb0745","doi-asserted-by":"crossref","first-page":"19546","DOI":"10.1073\/pnas.0609411103","article-title":"Gene transfer demonstrates that muscle is not a primary target for non-cell-autonomous toxicity in familial amyotrophic lateral sclerosis","volume":"103","author":"Miller","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2016.04.007_bb0750","first-page":"CD002064","article-title":"Recombinant human insulin-like growth factor I (rhIGF-I) for amyotrophic lateral sclerosis\/motor neuron disease","author":"Mitchell","year":"2002","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.nbd.2016.04.007_bb0755","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00401-012-1043-z","article-title":"Overexpression of human wild-type FUS causes progressive motor neuron degeneration in an age- and dose-dependent fashion","volume":"125","author":"Mitchell","year":"2013","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2016.04.007_bb0760","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/dmrr.751","article-title":"C-fos expression at the spinal dorsal horn of streptozotocin-induced diabetic rats","volume":"23","author":"Morgado","year":"2007","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.nbd.2016.04.007_bb0765","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.ejpain.2009.11.011","article-title":"Neuronal hyperactivity at the spinal cord and periaqueductal grey during painful diabetic neuropathy: effects of gabapentin","volume":"14","author":"Morgado","year":"2010","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.nbd.2016.04.007_bb0770","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.mcn.2011.07.008","article-title":"Reduced brain insulin-like growth factor I function during aging","volume":"49","author":"Muller","year":"2012","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.nbd.2016.04.007_bb0775","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1179\/016164105X39860","article-title":"Beneficial effects of intrathecal IGF-1 administration in patients with amyotrophic lateral sclerosis","volume":"27","author":"Nagano","year":"2005","journal-title":"Neurol. Res."},{"key":"10.1016\/j.nbd.2016.04.007_bb0780","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0301-0082(95)00024-P","article-title":"Apoptosis in the developing CNS","volume":"47","author":"Naruse","year":"1995","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nbd.2016.04.007_bb0785","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1002\/neu.480241203","article-title":"Insulin-like growth factors: putative muscle-derived trophic agents that promote motoneuron survival","volume":"24","author":"Neff","year":"1993","journal-title":"J. Neurobiol."},{"key":"10.1016\/j.nbd.2016.04.007_bb0790","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.neuroscience.2013.09.035","article-title":"Postnatal neuronal apoptosis in the cerebral cortex: physiological and pathophysiological mechanisms","volume":"254","author":"Nikolic","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2016.04.007_bb0795","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0091269","article-title":"Allele-specific knockdown of ALS-associated mutant TDP-43 in neural stem cells derived from induced pluripotent stem cells","volume":"9","author":"Nishimura","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2016.04.007_bb0800","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/nm.3232","article-title":"The role of autophagy in neurodegenerative disease","volume":"19","author":"Nixon","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.nbd.2016.04.007_bb0805","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.brainres.2009.08.012","article-title":"Intra-bone marrow-bone marrow transplantation slows disease progression and prolongs survival in G93A mutant SOD1 transgenic mice, an animal model mouse for amyotrophic lateral sclerosis","volume":"1296","author":"Ohnishi","year":"2009","journal-title":"Brain Res."},{"issue":"Suppl","key":"10.1016\/j.nbd.2016.04.007_bb0810","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/0022-510X(96)00087-1","article-title":"The quality of care and symptom control\u2014the effects on the terminal phase of ALS\/MND","volume":"139","author":"Oliver","year":"1996","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.nbd.2016.04.007_bb0815","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1136\/jnnp.69.2.199","article-title":"Increased expression of insulin-like growth factor I in skin in amyotrophic lateral sclerosis","volume":"69","author":"Ono","year":"2000","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.nbd.2016.04.007_bb0820","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.neuron.2015.10.027","article-title":"C9orf72 BAC transgenic mice display typical pathologic features of ALS\/FTD","volume":"88","author":"O'Rourke","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2016.04.007_bb0825","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/nn1789","article-title":"IGF-I specifically enhances axon outgrowth of corticospinal motor neurons","volume":"9","author":"Ozdinler","year":"2006","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2016.04.007_bb0830","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S0272-6386(98)70075-7","article-title":"Preferential expression of insulin-like growth factor binding proteins-1, -3, and -5 during early diabetic renal hypertrophy in rats","volume":"32","author":"Park","year":"1998","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.nbd.2016.04.007_bb0835","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/nrn1971","article-title":"Molecular biology of amyotrophic lateral sclerosis: insights from genetics","volume":"7","author":"Pasinelli","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2016.04.007_bb0840","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.neuron.2004.06.021","article-title":"Amyotrophic lateral sclerosis-associated SOD1 mutant proteins bind and aggregate with Bcl-2 in spinal cord mitochondria","volume":"43","author":"Pasinelli","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2016.04.007_bb0845","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s13311-014-0311-0","article-title":"Early-stage treatment with Withaferin A reduces levels of misfolded superoxide dismutase 1 and extends lifespan in a mouse model of amyotrophic lateral sclerosis","volume":"12","author":"Patel","year":"2015","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.nbd.2016.04.007_bb0850","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.neuron.2015.11.018","article-title":"Human C9ORF72 hexanucleotide expansion reproduces RNA foci and dipeptide repeat proteins but not neurodegeneration in BAC transgenic mice","volume":"88","author":"Peters","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2016.04.007_bb0855","first-page":"1","article-title":"Safety and clinical effects of mesenchymal stem cells secreting neurotrophic factor transplantation in patients with amyotrophic lateral sclerosis: results of phase 1\/2 and 2a clinical trials","author":"Petrou","year":"2016","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.nbd.2016.04.007_bb0860","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S1474-4422(11)70015-1","article-title":"Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease","volume":"10","author":"Philips","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2016.04.007_bb0865","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1001\/jama.290.10.1371","article-title":"New insights into diabetic polyneuropathy","volume":"290","author":"Polydefkis","year":"2003","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.nbd.2016.04.007_bb0870","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1111\/j.0953-816X.2004.03320.x","article-title":"In vivo effects of insulin-like growth factor-I (IGF-I) on prenatal and early postnatal development of the central nervous system","volume":"19","author":"Popken","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2016.04.007_bb0875","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1523\/JNEUROSCI.21-10-03369.2001","article-title":"Neuron-specific expression of mutant superoxide dismutase 1 in transgenic mice does not lead to motor impairment","volume":"21","author":"Pramatarova","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2016.04.007_bb0880","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/0169-328X(95)00116-A","article-title":"Differential spatio-temporal expression of the insulin-like growth factor genes in regenerating sciatic nerve","volume":"34","author":"Pu","year":"1995","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.nbd.2016.04.007_bb0885","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/(SICI)1097-4547(19990101)55:1<9::AID-JNR2>3.0.CO;2-J","article-title":"Insulin-like growth factor-II increases and IGF is required for postnatal rat spinal motoneuron survival following sciatic nerve axotomy","volume":"55","author":"Pu","year":"1999","journal-title":"J. Neurosci. Res."},{"issue":"Suppl. 1","key":"10.1016\/j.nbd.2016.04.007_bb0890","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1002\/dmrr.360","article-title":"Understanding the impact of painful diabetic neuropathy","volume":"19","author":"Quattrini","year":"2003","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.nbd.2016.04.007_bb0895","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1096\/fj.02-0183fje","article-title":"Targeted expression of IGF-1 transgene to skeletal muscle accelerates muscle and motor neuron regeneration","volume":"17","author":"Rabinovsky","year":"2003","journal-title":"FASEB J."},{"key":"10.1016\/j.nbd.2016.04.007_bb0900","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nm1205","article-title":"Silencing mutant SOD1 using RNAi protects against neurodegeneration and extends survival in an ALS model","volume":"11","author":"Ralph","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.nbd.2016.04.007_bb0905","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.nbd.2006.11.016","article-title":"Does diabetes mellitus target motor neurons?","volume":"26","author":"Ramji","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2016.04.007_bb0910","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nm1207","article-title":"Lentiviral-mediated silencing of SOD1 through RNA interference retards disease onset and progression in a mouse model of ALS","volume":"11","author":"Raoul","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.nbd.2016.04.007_bb0915","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0197-0186(88)90021-6","article-title":"Insulin and related growth factors: effects on the nervous system and mechanism for neurite growth and regeneration","volume":"12","author":"Recio-Pinto","year":"1988","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.nbd.2016.04.007_bb0920","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.neuron.2011.09.010","article-title":"A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD","volume":"72","author":"Renton","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2016.04.007_bb0925","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1227\/NEU.0b013e31825ca05f","article-title":"Intraspinal stem cell transplantation in amyotrophic lateral sclerosis: a phase I safety trial, technical note, and lumbar safety outcomes","volume":"71","author":"Riley","year":"2012","journal-title":"Neurosurgery"},{"key":"10.1016\/j.nbd.2016.04.007_bb0930","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1227\/NEU.0000000000000156","article-title":"Intraspinal stem cell transplantation in amyotrophic lateral sclerosis: a phase I trial, cervical microinjection, and final surgical safety outcomes","volume":"74","author":"Riley","year":"2014","journal-title":"Neurosurgery"},{"key":"10.1016\/j.nbd.2016.04.007_bb0935","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1073\/pnas.92.3.689","article-title":"Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis","volume":"92","author":"Ripps","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2016.04.007_bb0940","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nrn3430","article-title":"The changing scene of amyotrophic lateral sclerosis","volume":"14","author":"Robberecht","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2016.04.007_bb0945","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s12975-012-0177-6","article-title":"Immunological aspects in amyotrophic lateral sclerosis","volume":"3","author":"Rodrigues","year":"2012","journal-title":"Transl. Stroke Res."},{"key":"10.1016\/j.nbd.2016.04.007_bb0950","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/364362c0","article-title":"Mutations in Cu\/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis","volume":"364","author":"Rosen","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2016.04.007_bb0955","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nature03180","article-title":"Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression","volume":"433","author":"Rothstein","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2016.04.007_bb0960","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1056\/NEJM200105313442207","article-title":"Amyotrophic lateral sclerosis","volume":"344","author":"Rowland","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.nbd.2016.04.007_bb0965","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1055\/s-2007-978704","article-title":"Insulin-like growth factor-I prevents apoptosis in sympathetic neurons exposed to high glucose","volume":"31","author":"Russell","year":"1999","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.nbd.2016.04.007_bb0970","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/jnen\/59.7.575","article-title":"Insulin-like growth factor-I promotes myelination of peripheral sensory axons","volume":"59","author":"Russell","year":"2000","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2016.04.007_bb0975","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1000193","article-title":"Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosis","volume":"4","author":"Rutherford","year":"2008","journal-title":"PLoS Genet."},{"key":"10.1016\/j.nbd.2016.04.007_bb0980","doi-asserted-by":"crossref","first-page":"418","DOI":"10.3109\/17482968.2012.679944","article-title":"Functional improvement in mouse models of familial amyotrophic lateral sclerosis by PEGylated insulin-like growth factor I treatment depends on disease severity","volume":"13","author":"Saenger","year":"2012","journal-title":"Amyotroph. Lateral Scler."},{"key":"10.1016\/j.nbd.2016.04.007_bb0985","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/ncpneuro0504","article-title":"Diabetic neuropathy\u2014a review","volume":"3","author":"Said","year":"2007","journal-title":"Nat. Clin. Pract. Neurol."},{"key":"10.1016\/j.nbd.2016.04.007_bb0990","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007529","article-title":"Targeting RNA foci in iPSC-derived motor neurons from ALS patients with a C9ORF72 repeat expansion","volume":"5","author":"Sareen","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.nbd.2016.04.007_bb0995","first-page":"22","article-title":"Astrogliosis in ALS: possible interpretations according to pathogenetic hypotheses. Amyotroph Lateral Scler Other Motor","volume":"5","author":"Schiffer","year":"2004","journal-title":"Neuron. Disord."},{"issue":"Suppl","key":"10.1016\/j.nbd.2016.04.007_bb1000","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0022-510X(96)00073-1","article-title":"Reactive astrogliosis of the spinal cord in amyotrophic lateral sclerosis","volume":"139","author":"Schiffer","year":"1996","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.nbd.2016.04.007_bb1005","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/S0002-9440(10)65480-6","article-title":"Insulin-like growth factor I reverses experimental diabetic autonomic neuropathy","volume":"155","author":"Schmidt","year":"1999","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.nbd.2016.04.007_bb1010","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1080\/17482960701856300","article-title":"Design, power, and interpretation of studies in the standard murine model of ALS","volume":"9","author":"Scott","year":"2008","journal-title":"Amyotroph. Lateral Scler."},{"key":"10.1016\/j.nbd.2016.04.007_bb1015","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1111\/j.1582-4934.2009.00863.x","article-title":"Thymic involution, a co-morbidity factor in amyotrophic lateral sclerosis","volume":"14","author":"Seksenyan","year":"2010","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.nbd.2016.04.007_bb1020","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.2337\/dc06-0650","article-title":"Early involvement of the spinal cord in diabetic peripheral neuropathy","volume":"29","author":"Selvarajah","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.nbd.2016.04.007_bb1025","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1007\/s00125-008-1139-0","article-title":"Thalamic neuronal dysfunction and chronic sensorimotor distal symmetrical polyneuropathy in patients with type 1 diabetes mellitus","volume":"51","author":"Selvarajah","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.nbd.2016.04.007_bb1030","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1212\/01.WNL.0000142992.81995.F0","article-title":"A clinical trial of creatine in ALS","volume":"63","author":"Shefner","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2016.04.007_bb1035","doi-asserted-by":"crossref","first-page":"25266","DOI":"10.1074\/jbc.M113.492017","article-title":"Fused in sarcoma (FUS) protein lacking nuclear localization signal (NLS) and major RNA binding motifs triggers proteinopathy and severe motor phenotype in transgenic mice","volume":"288","author":"Shelkovnikova","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2016.04.007_bb1040","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1007\/s00018-003-3084-x","article-title":"New insights into the metabolic and molecular basis for diabetic neuropathy","volume":"60","author":"Sima","year":"2003","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.nbd.2016.04.007_bb1045","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s00401-015-1446-8","article-title":"Dysregulated IGFBP5 expression causes axon degeneration and motoneuron loss in diabetic neuropathy","volume":"130","author":"Simon","year":"2015","journal-title":"Acta Neuropathol."},{"issue":"Suppl. 2","key":"10.1016\/j.nbd.2016.04.007_bb1050","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1007\/s001250051402","article-title":"Modifications in the B10 and B26-30 regions of the B chain of human insulin alter affinity for the human IGF-I receptor more than for the insulin receptor","volume":"40","author":"Slieker","year":"1997","journal-title":"Diabetologia"},{"key":"10.1016\/j.nbd.2016.04.007_bb1055","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1530\/JME-12-0194","article-title":"IGFBP5 mediates high glucose-induced cardiac fibroblast activation","volume":"50","author":"Song","year":"2013","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.nbd.2016.04.007_bb1060","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1212\/01.wnl.0000335970.78664.36","article-title":"Subcutaneous IGF-1 is not beneficial in 2-year ALS trial","volume":"71","author":"Sorenson","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2016.04.007_bb1065","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1126\/science.1154584","article-title":"TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis","volume":"319","author":"Sreedharan","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.nbd.2016.04.007_bb1070","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.2337\/diabetes.49.11.1932","article-title":"Diabetic peripheral neuropathy: evidence for apoptosis and associated mitochondrial dysfunction","volume":"49","author":"Srinivasan","year":"2000","journal-title":"Diabetes"},{"key":"10.1016\/j.nbd.2016.04.007_bb1075","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.nbd.2010.06.017","article-title":"Progressive motor weakness in transgenic mice expressing human TDP-43","volume":"40","author":"Stallings","year":"2010","journal-title":"Neurobiol. Dis."},{"issue":"11\u20132","key":"10.1016\/j.nbd.2016.04.007_bb1080","first-page":"14","article-title":"Diabetes and bone health","volume":"25","author":"Strotmeyer","year":"2008","journal-title":"Diabetes Self Manag."},{"key":"10.1016\/j.nbd.2016.04.007_bb1085","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1084\/jem.20111313","article-title":"Deregulation of TDP-43 in amyotrophic lateral sclerosis triggers nuclear factor kappaB-mediated pathogenic pathways","volume":"208","author":"Swarup","year":"2011","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.nbd.2016.04.007_bb1090","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1523\/JNEUROSCI.19-06-02059.1999","article-title":"A role for insulin-like growth factor-I in the regulation of Schwann cell survival","volume":"19","author":"Syroid","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2016.04.007_bb1095","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2016.04.007_bb1100","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1038\/nprot.2007.418","article-title":"Induction of pluripotent stem cells from fibroblast cultures","volume":"2","author":"Takahashi","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.nbd.2016.04.007_bb1105","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1210\/jcem-63-3-651","article-title":"Serum insulin-like growth factor I levels in adult diabetic patients: the effect of age","volume":"63","author":"Tan","year":"1986","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.nbd.2016.04.007_bb1110","doi-asserted-by":"crossref","first-page":"23172","DOI":"10.1074\/jbc.M200141200","article-title":"Expression of insulin-like growth factor-binding protein 5 in neuroblastoma cells is regulated at the transcriptional level by c-Myb and B-Myb via direct and indirect mechanisms","volume":"277","author":"Tanno","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2016.04.007_bb1115","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/sj.cdd.4401546","article-title":"Silencing of endogenous IGFBP-5 by micro RNA interference affects proliferation, apoptosis and differentiation of neuroblastoma cells","volume":"12","author":"Tanno","year":"2005","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.nbd.2016.04.007_bb1120","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/SPC.0b013e32832b7df5","article-title":"Advances in the management of diabetic peripheral neuropathy","volume":"3","author":"Tesfaye","year":"2009","journal-title":"Curr. Opin. Support. Palliat. Care"},{"issue":"Suppl","key":"10.1016\/j.nbd.2016.04.007_bb1125","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/nn938","article-title":"Neurotrophins: from enthusiastic expectations through sobering experiences to rational therapeutic approaches","volume":"5","author":"Thoenen","year":"2002","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2016.04.007_bb1130","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1006\/exnr.1993.1173","article-title":"Trophic support of motoneurons: physiological, pathophysiological, and therapeutic implications","volume":"124","author":"Thoenen","year":"1993","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2016.04.007_bb1135","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1212\/WNL.50.3.772","article-title":"The peripheral insulin-like growth factor system in amyotrophic lateral sclerosis and in multiple sclerosis","volume":"50","author":"Torres-Aleman","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2016.04.007_bb1140","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/sj.mp.4002076","article-title":"Central actions of liver-derived insulin-like growth factor I underlying its pro-cognitive effects","volume":"12","author":"Trejo","year":"2007","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.nbd.2016.04.007_bb1145","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.brainres.2012.04.031","article-title":"Rodent models of TDP-43: recent advances","volume":"1462","author":"Tsao","year":"2012","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2016.04.007_bb1150","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1097\/00001756-200206120-00018","article-title":"Minocycline delays disease onset and mortality in a transgenic model of ALS","volume":"13","author":"Van Den Bosch","year":"2002","journal-title":"Neuroreport"},{"key":"10.1016\/j.nbd.2016.04.007_bb1155","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1126\/science.1165942","article-title":"Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6","volume":"323","author":"Vance","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.nbd.2016.04.007_bb1160","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/(SICI)1097-4547(19981215)54:6<840::AID-JNR12>3.0.CO;2-L","article-title":"Systemic administration of insulin-like growth factor decreases motor neuron cell death and promotes muscle reinnervation","volume":"54","author":"Vergani","year":"1998","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.nbd.2016.04.007_bb1165","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.2337\/diacare.15.12.1926","article-title":"Diabetic neuropathies","volume":"15","author":"Vinik","year":"1992","journal-title":"Diabetes Care"},{"key":"10.1016\/j.nbd.2016.04.007_bb1170","doi-asserted-by":"crossref","first-page":"396","DOI":"10.5966\/sctm.2011-0061","article-title":"Amyotrophic lateral sclerosis model derived from human embryonic stem cells overexpressing mutant superoxide dismutase 1","volume":"1","author":"Wada","year":"2012","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.nbd.2016.04.007_bb1175","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1007\/s00415-004-0481-5","article-title":"Rasagiline alone and in combination with riluzole prolongs survival in an ALS mouse model","volume":"251","author":"Waibel","year":"2004","journal-title":"J. Neurol."},{"issue":"1","key":"10.1016\/j.nbd.2016.04.007_bb9000","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.celrep.2014.03.019","article-title":"Intrinsic membrane hyperexcitability of amyotrophic lateral sclerosis patient-derived motor neurons","volume":"7","author":"Wainger","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.nbd.2016.04.007_bb1180","doi-asserted-by":"crossref","first-page":"6920","DOI":"10.1523\/JNEUROSCI.22-16-06920.2002","article-title":"Neuroprotective effects of glial cell line-derived neurotrophic factor mediated by an adeno-associated virus vector in a transgenic animal model of amyotrophic lateral sclerosis","volume":"22","author":"Wang","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2016.04.007_bb1185","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1093\/hmg\/ddg312","article-title":"Copper-binding-site-null SOD1 causes ALS in transgenic mice: aggregates of non-native SOD1 delineate a common feature","volume":"12","author":"Wang","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2016.04.007_bb1190","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1093\/hmg\/ddi236","article-title":"Somatodendritic accumulation of misfolded SOD1-L126Z in motor neurons mediates degeneration: alphaB-crystallin modulates aggregation","volume":"14","author":"Wang","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2016.04.007_bb1195","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.molbrainres.2004.11.019","article-title":"Mouse motor neuron disease caused by truncated SOD1 with or without C-terminal modification","volume":"135","author":"Watanabe","year":"2005","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.nbd.2016.04.007_bb1200","doi-asserted-by":"crossref","first-page":"18809","DOI":"10.1073\/pnas.0908767106","article-title":"TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration","volume":"106","author":"Wegorzewska","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2016.04.007_bb1205","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1159\/000085764","article-title":"Insulin-like growth factor system in amyotrophic lateral sclerosis","volume":"9","author":"Wilczak","year":"2005","journal-title":"Endocr. Dev."},{"key":"10.1016\/j.nbd.2016.04.007_bb1210","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0140-6736(03)12828-0","article-title":"Free insulin-like growth factor (IGF)-I and IGF binding proteins 2, 5, and 6 in spinal motor neurons in amyotrophic lateral sclerosis","volume":"361","author":"Wilczak","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.nbd.2016.04.007_bb1215","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.1073\/pnas.0912417107","article-title":"TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration","volume":"107","author":"Wils","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2016.04.007_bb1220","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/0896-6273(95)90259-7","article-title":"An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria","volume":"14","author":"Wong","year":"1995","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2016.04.007_bb1225","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1006\/exnr.1994.1189","article-title":"Early reduction in insulin-like growth factor gene expression in diabetic nerve","volume":"130","author":"Wuarin","year":"1994","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2016.04.007_bb1230","doi-asserted-by":"crossref","first-page":"10851","DOI":"10.1523\/JNEUROSCI.1630-10.2010","article-title":"Wild-type human TDP-43 expression causes TDP-43 phosphorylation, mitochondrial aggregation, motor deficits, and early mortality in transgenic mice","volume":"30","author":"Xu","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2016.04.007_bb1235","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cell.2009.03.034","article-title":"A fresh look at iPS cells","volume":"137","author":"Yamanaka","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2016.04.007_bb1240","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nn2047","article-title":"Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis","volume":"11","author":"Yamanaka","year":"2008","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2016.04.007_bb1245","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1212\/WNL.0b013e3181f07e0c","article-title":"Frameshift and novel mutations in FUS in familial amyotrophic lateral sclerosis and ALS\/dementia","volume":"75","author":"Yan","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2016.04.007_bb1250","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.stem.2013.04.003","article-title":"A small molecule screen in stem-cell-derived motor neurons identifies a kinase inhibitor as a candidate therapeutic for ALS","volume":"12","author":"Yang","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.nbd.2016.04.007_bb1255","doi-asserted-by":"crossref","first-page":"6041","DOI":"10.1523\/JNEUROSCI.22-14-06041.2002","article-title":"Myelination is altered in insulin-like growth factor-I null mutant mice","volume":"22","author":"Ye","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2016.04.007_bb1260","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0037258","article-title":"Dihydrotestosterone ameliorates degeneration in muscle, axons and motoneurons and improves motor function in amyotrophic lateral sclerosis model mice","volume":"7","author":"Yoo","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2016.04.007_bb1265","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/0896-6273(95)90217-1","article-title":"Evidence for an important role of IGF-I and IGF-II for the early development of chick sympathetic neurons","volume":"14","author":"Zackenfels","year":"1995","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2016.04.007_bb1270","doi-asserted-by":"crossref","first-page":"3638","DOI":"10.1093\/emboj\/20.14.3638","article-title":"The interaction of insulin-like growth factor-I with the N-terminal domain of IGFBP-5","volume":"20","author":"Zeslawski","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/j.nbd.2016.04.007_bb1275","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nature14973","article-title":"The C9orf72 repeat expansion disrupts nucleocytoplasmic transport","volume":"525","author":"Zhang","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2016.04.007_bb1280","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.nbd.2012.07.008","article-title":"Regulatory T lymphocytes from ALS mice suppress microglia and effector T lymphocytes through different cytokine-mediated mechanisms","volume":"48","author":"Zhao","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2016.04.007_bb1285","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/417074a","article-title":"Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice","volume":"417","author":"Zhu","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2016.04.007_bb1290","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1006\/exnr.1996.0129","article-title":"Insulin-like growth factors reverse or arrest diabetic neuropathy: effects on hyperalgesia and impaired nerve regeneration in rats","volume":"140","author":"Zhuang","year":"1996","journal-title":"Exp. Neurol."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996116300894?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996116300894?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T23:39:09Z","timestamp":1748907549000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996116300894"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":259,"alternative-id":["S0969996116300894"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2016.04.007","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insulin-like growth factor 1 in diabetic neuropathy and amyotrophic lateral sclerosis","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2016.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}